Pharmabiz

OneSource supports second generic semaglutide approval in Canada

OneSource supports second generic semaglutide approval in Canada: Our Bureau, Bengaluru Thursday, May 7, 2026, 14:45 Hrs [IST] OneSource Specialty Pharma, a leading specialty phar ...
Pharmabiz

Venus Remedies secures its first marketing authorization in Argentina, expands Latin America footprint

Venus Remedies secures its first marketing authorization in Argentina, expands Latin America footprint: Our Burau, Bengaluru Thursday, May 7, 2026, 14:30 Hrs [IST] Venus Remedies, ...
Pharmabiz

Norgine welcomes TGA registration in Australia of Pedmarqsi for prevention of cisplatin-induced hearing loss in children

Norgine welcomes TGA registration in Australia of Pedmarqsi for prevention of cisplatin-induced hearing loss in children: Amsterdam, The Netherlands Thursday, May 7, 2026, 14:00 H ...
Pharmabiz

Samsung announces world-first breakthrough in fainting prediction with Galaxy Watch

Samsung announces world-first breakthrough in fainting prediction with Galaxy Watch: Our Bureau, Bengaluru Thursday, May 7, 2026, 13:45 Hrs [IST] Samsung Electronics in a joint cl ...
Pharmabiz

Neuland enters development collaboration with LIR Life Sciences for transdermal GLP-1

Neuland enters development collaboration with LIR Life Sciences for transdermal GLP-1: Our Bureau, Bengaluru Thursday, May 7, 2026, 13:30 Hrs [IST] Neuland Laboratories, a global ...
Pharmabiz

Atossa Therapeutics receives US FDA rare paediatric disease designation for (Z)-Endoxifen for McCune-Albright syndrome

Atossa Therapeutics receives US FDA rare paediatric disease designation for (Z)-Endoxifen for McCune-Albright syndrome: Seattle Thursday, May 7, 2026, 12:00 Hrs [IST] Atossa Thera ...
Pharmabiz

ZYUS Life Sciences receives US patent entitled ‘Cannabichromene formulation for pain management’

ZYUS Life Sciences Corporation, a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, announced that the ...
Pharmabiz

J&J investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease

J&J investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease: Chicago, Illinois Thursd ...
Pharmabiz

Bayer to acquire biopharma company Perfuse Therapeutics in up to $2.45 billion deal

Bayer to acquire biopharma company Perfuse Therapeutics in up to $2.45 billion deal: Berlin, Germany Bayer, a global enterprise with core co ...
Pharmabiz

IPA urges Union health minister to withdraw new DCGI recruitment rules citing statutory violations

IPA urges Union health minister to withdraw new DCGI recruitment rules citing statutory violations: Peethaambaran Kunnathoor, ...
Pharmabiz

Commerce ministry seeks industry inputs to strengthen pharma and medical device supply chains

Commerce ministry seeks industry inputs to strengthen pharma and medical device supply chains: Shardul Nautiyal, Mumbai Thursday, May 7, 2026, 08:00 Hrs [IST] In a significant mov ...
Pharmabiz

Indian healthcare industry’s approach to pain management shifts from pharmaceuticals to medical devices

Indian healthcare industry’s approach to pain management is undergoing a structural shift, driven by the growing burden of chronic conditions, changing patient expectations, and rapid advances in ...